MedTrace Logo

Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO)

NCT01088672 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-07-17

Study results available
· View outcomes & findings →

Summary

To determine the revascularization rate of the CE-marked Trevo device in large vessel occlusions in ischemic stroke patients.

* Revascularization, defined as at least TICI 2a in the vascular territory treated at end of the neuro interventional procedure.

Conditions

Interventions

PROCEDURE

Mechanical Thrombectomy

The Trevo device is intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke.

Sponsors & Collaborators

  • Stryker Neurovascular

    lead INDUSTRY

Principal Investigators

  • Nils Wahlgren, MD · Karolinska University Hospital in Solna

  • Olav Jansen, MD · Universitätsklinikum Schleswig-Holstein - Campus Kiel UK S-H

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-08-31
Completion
2011-11-30

Countries

  • Austria
  • Germany
  • Spain
  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088672 on ClinicalTrials.gov